GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Merus NV (FRA:2GH) » Definitions » Other Gross PPE

Merus NV (FRA:2GH) Other Gross PPE : €26.33 Mil (As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Merus NV Other Gross PPE?

Merus NV's Other Gross PPE for the quarter that ended in Dec. 2024 was €26.33 Mil.

Merus NV's quarterly Other Gross PPE declined from Jun. 2024 (€20.79 Mil) to Sep. 2024 (€20.24 Mil) but then increased from Sep. 2024 (€20.24 Mil) to Dec. 2024 (€26.33 Mil).

Merus NV's annual Other Gross PPE increased from Dec. 2022 (€26.51 Mil) to Dec. 2023 (€26.73 Mil) but then declined from Dec. 2023 (€26.73 Mil) to Dec. 2024 (€26.33 Mil).


Merus NV Other Gross PPE Historical Data

The historical data trend for Merus NV's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merus NV Other Gross PPE Chart

Merus NV Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.99 8.34 26.51 26.73 26.33

Merus NV Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.73 20.34 20.79 20.24 26.33

Merus NV Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Merus NV Business Description

Traded in Other Exchanges
Address
Uppsalalaan 17, Utrecht, NLD, 3584 CT
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

Merus NV Headlines

No Headlines